1. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
2. Vescina C, Agosti M, Oderiz Ret al.Changing epidemiology for serotypes causing pneumococcal invasive disease. Presented at:7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel, 14–18 March 2010.
3. Moore M, Farley M, Schaffner Wet al.Trends in invasive pneumococcal disease among children <5 years of age, United States, 1998–2008. Presented at:7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel, 14–18 March 2010.
4. Moore M, Farley M, Schaffner Wet al.Trends in invasive pneumococcal disease among adults, United States, 1998–2008. Presented at:7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel, 14–18 March 2010.
5. Pillai D, Shahinas D, Low D. Whole genome sequencing of multi-drug resistant (MDR) serotype 19AStreptococcus pneumoniae(SPN) in Canada. Presented at:7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel, 14–18 March 2010.